Transgenic fish - Where we are and where do we go?

Rex A. Dunham, Zhanjiang Liu

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Transgenic fish have been developed that have improved growth, color, disease resistance, survival in cold, and body composition, and produce pharmaceutical proteins. Transgenes elicit pleiotropic effects, some positive and some negative. In general, transgenic fish appear to have lower fitness than controls and pose little environmental risk, but this research is not fully conclusive. Transgenic zebrafish with altered coloration have been commercialized and growth hormone transgenic salmon, carp, and tilapia are near commercialization. To enhance commercialization and minimize environmental risk, additional technologies such as transgenic sterilization need to be developed. Genomic research has produced an abundance of molecular genetic information including many genes for consideration for gene transfer, highly regulated gene promoters, and knowledge about their expression and function. Functional genomics analysis should be applied in the future to enhance the capacity and versatility of transgenic technology.

Original languageEnglish (US)
Pages (from-to)297-319
Number of pages23
JournalIsraeli Journal of Aquaculture - Bamidgeh
Volume58
Issue number4
StatePublished - Dec 1 2006
Externally publishedYes

Keywords

  • Commercialization
  • Disease resistance
  • Gene transfer
  • Growth
  • Transgenic fish

ASJC Scopus subject areas

  • Aquatic Science
  • Agronomy and Crop Science

Fingerprint Dive into the research topics of 'Transgenic fish - Where we are and where do we go?'. Together they form a unique fingerprint.

  • Cite this